Biological variability of glycated hemoglobin

Area of Science:

• Clinical Chemistry
• Endocrinology
• Diabetes Mellitus Research

Background:

• Glycated hemoglobin (HbA1c) is crucial for monitoring glycemic control in diabetic patients.
• The American Diabetes Association recommends HbA1c for diabetes diagnosis, yet clinically allowable measurement error is undefined.
• Biological variability data is essential for defining analytical goals for HbA1c.

Purpose of the Study:

• To systematically review existing literature on the biological variation of HbA1c.
• To assess the consistency of available data on HbA1c biological variability.
• To define accurate analytical goals for HbA1c measurement.

Main Methods:

• Systematic literature review of studies measuring HbA1c biological variation.
• Analysis of data consistency across selected studies.
• Evaluation of methodologies, population selection, protocols, and statistical analyses in recruited studies.

Main Results:

• Nine studies were included in the review.
• Significant limitations were identified in the recruited studies, including analytic methodology, population selection, protocol application, and statistical analyses.
• Inconsistency in available data hinders the accurate definition of analytical goals for HbA1c.

Conclusions:

• There is a critical need to determine the biological variability of HbA1c.
• Future research must utilize specific and traceable assays.
• Appropriate protocols and statistical evaluation are necessary for reliable determination of HbA1c biological variability.